Litigation Details for IN RE ASACOL ANTITRUST LITIGATION (D. Mass. 2015)

IN RE ASACOL ANTITRUST LITIGATION (D. Mass. 2015)

Docket		Date Filed	2015-06-22
Court	District Court, D. Massachusetts	Date Terminated	2019-09-05
Cause	28:1332 Diversity-(Citizenship)	Assigned To	Denise Jefferson Casper
Jury Demand	Both	Referred To
Parties	ALLERGAN, PLC
Patents	6,649,180; 6,893,662; 8,580,302
Attorneys	Bryan Grant
Firms	Bryan Grant
Link to Docket	External link to docket

Details for IN RE ASACOL ANTITRUST LITIGATION (D. Mass. 2015)

Date Filed	Document No.	Description	Snippet	Link To Document
2015-06-22	1	Complaint	on Delzicol® is covered by U.S. Patent No. 6,649,180 (“the ‘180 patent”), which expires April 13, 2020…drug sales due to patent expiration has become known as the “patent cliff.” The patent cliff represents…“the ‘170 patent”) and 5,541,171 (“the ‘171 patent”). Both patents expired July 30, 2013. 34…equivalents, and any patents that purportedly protect each drug. 12. Drug patents typically last…which the patent issues and ending 20 years from the date on which the application for the patent was filed	External link to document
2016-07-20	110	Memorandum & ORDER	11. The Orange Book lists U.S. Patent No. 6,649,180 (“the ’180 patent”) for Delzicol, which expires on…Orange Book lists two patents for Asacol, U.S. Patent Nos. 5,541,170 (“the ’170 patent”) and 5,541,171 (… (“the ’171 patent”). Id. ¶ 67. Both patents expired July 30, 2013. Id. In May 2008, the FDA approved…. ¶ 73. The Orange Book lists two patents for Asacol HD, U.S. Patent Nos. 6,893,662 and 8,580,302. Id…applicable patents are invalid or will not be infringed by the proposed generic drug. Id. If the patent owner	External link to document